Analysis of postrevascularization syndrome after orthotopic liver transplantation: the experience of an Australian liver transplantation center
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
We investigated the causes and examined patient outcomes following the postrevascularization syndrome (PRS) during orthotopic liver transplantation (OLTx).
PRS was defined as a fall in the mean arterial pressure at 5 min after revascularization to less than 70% of the baseline and lasting for 5 min. Data from 100 adult patients who underwent OLTx between January 1998 and September 2000 were analyzed. Analyzed data included donor and recipient demographic data, recipient operative and postoperative courses, and recipient outcome.
Twenty-nine patients (29%) exhibited PRS during OLTx (PRS group). There was a higher incidence of older donors (>50 years) in the PRS group (48% vs 23%; P < 0.05). Postrevascularization hyperkalemia and metabolic acidosis were observed in both the PRS and non-PRS groups. Transaminase and lactate levels after revascularization were significantly higher in the PRS group (P < 0.05). Alkaline phosphatase and gamma-glutamyl transpeptidase levels on day 7 tended to be higher in the PRS group; although the difference was not significant (p ≧ 0.05). Serum creatinine was significantly elevated on day 7 in the PRS group (P < 0.01).
Our results indicate that PRS following OLTx tended to be more common in liver allografts from older donors and was associated with posttransplantation liver and renal dysfunction.
- Analysis of postrevascularization syndrome after orthotopic liver transplantation: the experience of an Australian liver transplantation center
Journal of Hepato-Biliary-Pancreatic Surgery
Volume 8, Issue 6 , pp 557-563
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Key words Postrevascularization syndrome
- Orthotopic liver transplantation
- Older donor
- Liver dysfunction
- Renal dysfunction
- Industry Sectors
- Author Affiliations
- A1. Australian National Liver Transplantation Unit (ANLTU), Royal Prince Alfred Hospital, University of Sydney, Camperdown, Sydney, NSW 2050, Australia, AU